Cargando…
HIV-1 disease progression in immune-competent HIV-1-infected and breastfeeding mothers participating in the ANRS 12174 clinical trial in Burkina Faso, South Africa, Uganda and Zambia: a cohort study
OBJECTIVE: We have assessed HIV-1 disease progression among HIV-1-positive mothers in relation to duration of any or exclusive breast feeding in the context of ANRS 12174 trial. METHODS: The analysis was completed on 203, 212, 272 and 529 HIV-1-positive and lactating mothers with CD4 count >350 c...
Autores principales: | Somé, Eric Nagaonle, Engebretsen, Ingunn M S, Nagot, Nicolas, Meda, Nicolas Yelbomkan, Vallo, Roselyne, Kankasa, Chipepo, Tumwine, James K, Singata-Madliki, Mandisa, Harper, Kim, Hofmeyr, G Justus, Van de Perre, Philippe, Tylleskär, Thorkild |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892762/ https://www.ncbi.nlm.nih.gov/pubmed/29626043 http://dx.doi.org/10.1136/bmjopen-2017-019239 |
Ejemplares similares
-
Changes in body mass index and hemoglobin concentration in breastfeeding women living with HIV with a CD4 count over 350: Results from 4 African countries (The ANRS 12174 trial)
por: Somé, Eric Nagaonlé, et al.
Publicado: (2017) -
Breastfeeding patterns and its determinants among mothers living with Human Immuno-deficiency Virus -1 in four African countries participating in the ANRS 12174 trial
por: Somé, Eric N., et al.
Publicado: (2017) -
Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174
por: Nagot, Nicolas, et al.
Publicado: (2012) -
Mitochondrial DNA Parameters in Blood of Infants Receiving Lopinavir/Ritonavir or Lamivudine Prophylaxis to Prevent Breastfeeding Transmission of HIV-1
por: Monnin, Audrey, et al.
Publicado: (2020) -
Longitudinal Follow-Up of Blood Telomere Length in HIV-Exposed Uninfected Children Having Received One Year of Lopinavir/Ritonavir or Lamivudine as Prophylaxis
por: Monnin, Audrey, et al.
Publicado: (2021)